Leber's disease, a condition where the body does not produce enough of a certain enzyme, can also be treated with Methylcobalamin
The compounds could potentially be combined, as their mechanisms do not overlap
Studied for raising nicotinamide availability and NAD levels, with associated effects on mitochondrial efficiency and metabolic rate
Its core pathological feature is excessive accumulation of adipose tissue, accompanied by abnormal proliferation, differentiation, and metabolic dysfunction of adipocytes, which in turn induce a series of complications including insulin resistance, nonalcoholic fatty liver disease, and cardiovascular diseases
To be handled only by qualified professionals in controlled laboratory settings
In some countries hydroxocobalamin has completely replaced cyanocobalamin as first choice for vitamin B 12 therapy because it is retained in the body longer and can be administered at intervals of up to three months